MARKET

ERNA

ERNA

Ernexa
NASDAQ
0.2020
-0.0062
-2.98%
After Hours: 0.2030 +0.001 +0.50% 19:56 03/27 EDT
OPEN
0.2106
PREV CLOSE
0.2082
HIGH
0.2106
LOW
0.2020
VOLUME
209.51K
TURNOVER
--
52 WEEK HIGH
4.049
52 WEEK LOW
0.2010
MARKET CAP
5.89M
P/E (TTM)
-0.0904
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at ERNA last week (0316-0320)?
Weekly Report · 5d ago
Eterna Therapeutics Faces Nasdaq Delisting Risk After Notice
TipRanks · 03/20 21:36
Ernexa Therapeutics faces Nasdaq delisting notice after bid price falls below $1 for 30 days
Reuters · 03/20 21:01
Ernexa Therapeutics files $50M mixed securities shelf
TipRanks · 03/16 10:56
Weekly Report: what happened at ERNA last week (0309-0313)?
Weekly Report · 03/16 10:23
ERNEXA THERAPEUTICS INC - MAY OFFER UP TO $50 MLN OF SECURITIES - SEC FILING
Reuters · 03/16 10:01
Ernexa Therapeutics FY 2025 net loss narrows 68% to USD 14.08 million
Reuters · 03/13 21:23
Weekly Report: what happened at ERNA last week (0302-0306)?
Weekly Report · 03/09 10:23
More
About ERNA
Ernexa Therapeutics Inc., formerly Eterna Therapeutics Inc., is a preclinical-stage company. The Company is focused on using cutting-edge gene-editing tools to deliver safe off-the-shelf cell therapies for the treatment of advanced solid tumors. Its Pipeline includes ERNA-101, and ERNA-102. Its core technology utilizes engineer allogenic-induced pluripotent stem cells (iPSCs) to express genes of interest and to efficiently differentiate these cells into mesenchymal stem cells (iMSCs). The Company seeks to capitalize on the intrinsic tumor-homing ability of MSCs to slip through the tumor’s defenses and to deliver potent pro-inflammatory factors directly to the tumor microenvironment (TME), thus unleashing potent anti-cancer immune responses. The Company is focused on developing iPSC-derived iMSC that express critical factors, such as pro-inflammatory cytokines.

Webull offers Ernexa Therapeutics Inc stock information, including NASDAQ: ERNA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ERNA stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ERNA stock methods without spending real money on the virtual paper trading platform.